166 related articles for article (PubMed ID: 2833270)
1. Effects of the desensitization by morphine of the opiate-dependent adenylate cyclase system in the rat striatum on the activity of the inhibitory regulatory G protein.
Tirone F; Viganó A; Groppetti A; Parenti M
Biochem Pharmacol; 1988 Mar; 37(6):1039-44. PubMed ID: 2833270
[TBL] [Abstract][Full Text] [Related]
2. Opiate receptor-mediated inhibition of adenylate cyclase in rat striatal plasma membranes.
Cooper DM; Londos C; Gill DL; Rodbell M
J Neurochem; 1982 Apr; 38(4):1164-7. PubMed ID: 6278084
[TBL] [Abstract][Full Text] [Related]
3. Involvement of a high-affinity GTPase in the inhibitory coupling of striatal muscarinic receptors to adenylate cyclase.
Onali P; Olianas MC; Schwartz JP; Costa E
Mol Pharmacol; 1983 Nov; 24(3):380-6. PubMed ID: 6138702
[TBL] [Abstract][Full Text] [Related]
4. Modification of guanine nucleotide-regulatory components in brain membranes. II. Relationship of guanosine 5'-triphosphate effects on opiate receptor binding and coupling receptors with adenylate cyclase.
Childers SR; LaRiviere G
J Neurosci; 1984 Nov; 4(11):2764-71. PubMed ID: 6094742
[TBL] [Abstract][Full Text] [Related]
5. Opiate tolerance and dependence is associated with a decreased activity of GTPase in rat striatal membranes.
Parenti M; Gazzotti G; Tirone F; Groppetti A
Life Sci; 1983; 33 Suppl 1():345-8. PubMed ID: 6141494
[TBL] [Abstract][Full Text] [Related]
6. Selective alterations in guanine nucleotide regulation of opiate receptor binding and coupling with adenylate cyclase.
Childers SR; Lambert SM; La Riviere G
Life Sci; 1983; 33 Suppl 1():215-8. PubMed ID: 6319864
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.
Duman RS; Tallman JF; Nestler EJ
J Pharmacol Exp Ther; 1988 Sep; 246(3):1033-9. PubMed ID: 2843624
[TBL] [Abstract][Full Text] [Related]
8. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
O'Shaughnessy CT; Headley PM
Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
10. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of enkephalin activity in neuroblastoma X glioma NG108-15 hybrid cells by phospholipases.
Law PY; Griffin MT; Koehler JE; Loh HH
J Neurochem; 1983 Jan; 40(1):267-75. PubMed ID: 6294248
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of adenylate cyclase by GTP and its modulation by opiate receptor in rat caudate nucleus.
Kamikubo K; Nozaki M; Fujimura H
Jpn J Pharmacol; 1981 Apr; 31(2):175-84. PubMed ID: 6273623
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of a low Km GTPase activity in rat striatum by calmodulin.
Treisman GJ; Muirhead N; Iwaniec L; Gnegy ME
J Neurochem; 1985 Feb; 44(2):518-25. PubMed ID: 2981286
[TBL] [Abstract][Full Text] [Related]
14. Demonstration and characterization of opiate inhibition of the striatal adenylate cyclase.
Law PY; Wu J; Koehler JE; Loh HH
J Neurochem; 1981 May; 36(5):1834-46. PubMed ID: 7241139
[TBL] [Abstract][Full Text] [Related]
15. GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells.
Vachon L; Costa T; Herz A
Mol Pharmacol; 1987 Feb; 31(2):159-68. PubMed ID: 3027528
[TBL] [Abstract][Full Text] [Related]
16. Role of adenosine 3',5'-monophosphate and the Ri-receptor Gi-coupled adenylate cyclase inhibitory pathway in the mechanism whereby adrenalectomy increases the adenosine antilipolytic effect in rat fat cells.
de Mazancourt P; Lacasa D; Giot J; Giudicelli Y
Endocrinology; 1989 Mar; 124(3):1131-9. PubMed ID: 2465135
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptors negatively coupled to adenylate cyclase in rat myocardial sarcolemma. Involvement of inhibitory guanine nucleotide regulatory protein.
Anand-Srivastava MB
Biochem Pharmacol; 1989 Feb; 38(3):489-96. PubMed ID: 2492805
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
Onali P; Olianas MC
Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
[TBL] [Abstract][Full Text] [Related]
19. A mu-opiate receptor in 7315c tumor tissue mediates inhibition of immunoreactive prolactin release and adenylate cyclase activity.
Frey EA; Kebabian JW
Endocrinology; 1984 Nov; 115(5):1797-804. PubMed ID: 6092035
[TBL] [Abstract][Full Text] [Related]
20. Opioids, noradrenaline and GTP analogs inhibit cholera toxin activated adenylate cyclase in neuroblastoma x glioma hybrid cells.
Propst F; Hamprecht B
J Neurochem; 1981 Feb; 36(2):580-8. PubMed ID: 6257856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
